SAN DIEGO--(BUSINESS WIRE)--Aug. 8, 2006--Aethlon Medical, Inc. (OTCBB:AEMD - News), a pioneer in developing therapeutic devices for infectious disease, announced today that it will present at The AIDS Institute’s Treatment Horizons Forum in conjunction with the upcoming AIDS 2006 - XVI International AIDS Conference to be held in Toronto, Canada. Aethlon Chairman and CEO James A. Joyce will present the Company’s 2006 regulatory initiatives, and will review recent human safety data of its Hemopurifier(TM), a therapeutic device targeted to treat drug and vaccine resistant pathogens, including HIV, the AIDS virus.
